CCR funding completed

Summary by AI ^BETAClose X

Ampeak Energy Limited has successfully completed its loan agreement with Cardiff Capital Region, receiving the final tranche of £3.5 million, bringing the total loan amount to £8.5 million. This funding, which was contingent on planning permission for the AW2 battery storage project and the expiry of its judicial review period, will be used to accelerate the development of the company's battery storage projects.

Disclaimer*

Ampeak Energy Limited

20 November 2025

A black background with white text AI-generated content may be incorrect.

AMPEAK ENERGY LIMITED

("Ampeak Energy" or the "Company")

CCR funding completed

Ampeak Energy is pleased to advise that it has received the final tranche of £3.5m of the £8.5m loan from Cardiff Capital Region ("CCR"), first announced on 16th April 2025.

The final payment was made following the receipt of planning permission, as announced on 1 October 2025, and the expiry of the Judicial Review period for the AW2 battery storage project.

Ampeak Energy will utilise these funds to further accelerate the delivery of its exciting pipeline of battery storage projects.

For further information, please contact:

Ampeak Energy Sean Parsons	+44 (0)7739832446

Strand Hanson Limited (Nominated and Financial Adviser) Richard Johnson Rory Murphy David Asquith	+44 (0)20 7409 3494

Zeus Capital Limited (Broker) Louisa Waddell Simon Johnson	+44 (0)20 3829 5000

Notes to Editors

Ampeak Energy is a global developer, owner and operator of sustainable energy projects. Ampeak Energy owns the world's flagship tidal stream project, MeyGen, and the Uskmouth Power Station site, which is being repurposed into a sustainable energy park that will become one of the UK's largest battery energy storage sites. www.ampeak.energy

Ampeak Energy's strategy: "Building a Sustainable Future to 2035", can be viewed here

Proud to be part of London's universe of Green Economy Equities

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END